Veeva Systems Inc. ( NYSE:VEEV ) recently posted some strong earnings, and the market responded positively. We ...
Veeva Systems (NYSE: VEEV) today announced Veeva SiteVault CTMS, a clinical trial management system for research sites that ...
EVERSANA – pharmaphorum's parent company – said it has met the standard to join Veeva's partner programme and will now be ...
Veeva Systems (VEEV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review ...
Shares of Veeva Systems Inc. (NYSE:VEEV – Get Free Report) have been assigned an average recommendation of “Moderate Buy” ...
As predicted by many analysts, economists, and investors, the sweeping tariffs announced by the Trump administration on ...
Veeva Systems Inc. (NYSE:VEEV), a leading provider of cloud-based software solutions for the global life sciences industry with a market capitalization of $37.4 billion, continues to navigate a ...
Research analysts at Zacks Research upped their Q1 2026 earnings per share estimates for Veeva Systems in a report released on Wednesday, March 26th. Zacks Research analyst R. Department now ...
Veeva Systems's VEEV short percent of float has fallen 10.0% since its last report. The company recently reported that it has ...
PLEASANTON, Calif., April 1, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva SiteVault CTMS, a clinical trial management system for research sites that is integrated with ...
In a report released today, Saket Kalia from Barclays maintained a Buy rating on Veeva Systems (VEEV – Research Report), with a price target of ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...